Not sure where you get the idea that time to bowl movement wouldn't be important to chronic pain users or that PGNX/Salix isn't focused on the chronic pain market. I am also not sure why you don't think a 2 year lead wouldn't be significant if two drugs were equal.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.